ENSC
Price:
$0.2713
Market Cap:
$2.52M
Ensysce Biosciences, Inc. is a clinical-stage pharmaceutical firm dedicated to developing novel prescription drugs for the treatment of severe pain in the United States, with a specific focus on preventing opioid addiction, misuse, abuse, and overdose. The company leverages two primary technological frameworks: the Trypsin Activated Abuse Protection (TAAP) platform, which creates opioid prodrugs designed to resist abuse, and the Multi-Pill Abuse Resistance (MPAR) platform, engineered to offer protection against overdose through its advanced opioid prodrug technology. Ensysce's pipeline features several key candidates, including PF614, an oxycodone prodrug developed using the TAAP platform, c...[Read more]
Industry
Biotechnology
IPO Date
2018-03-14
Stock Exchange
NASDAQ
Ticker
ENSC
According to Ensysce Biosciences, Inc.’s latest financial reports and current stock price. The company's current ROE is -631.47%. This represents a change of -521.88% compared to the average of 149.68% of the last 4 quarters.
The mean historical ROE of Ensysce Biosciences, Inc. over the last ten years is 436.10%. The current -631.47% ROE has changed -244.80% with respect to the historical average. Over the past ten years (40 quarters), ENSC's ROE was at its highest in in the September 2021 quarter at 16.24%. The ROE was at its lowest in in the March 2023 quarter at -1312.26%.
Average
436.10%
Median
-0.02%
Minimum
-316.63%
Maximum
3.29%
Discovering the peaks and valleys of Ensysce Biosciences, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 4.16%
Maximum Annual ROE = 3.29%
Minimum Annual Increase = -41983.36%
Minimum Annual ROE = -316.63%
| Year | ROE | Change |
|---|---|---|
| 2025 | -316.63% | 47.02% |
| 2024 | -215.37% | -106.55% |
| 2023 | 3.29% | 405.13% |
| 2022 | 650.76% | 76.28% |
| 2021 | 369.16% | -41983.36% |
| 2020 | -0.88% | -100.58% |
| 2019 | 151.32% | -22340.29% |
| 2018 | -0.68% | 4.16% |
The current ROE of Ensysce Biosciences, Inc. (ENSC) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
918.40%
5-year avg
755.03%
10-year avg
436.10%
Ensysce Biosciences, Inc.’s ROE is greater than Soligenix, Inc. (-246.04%), less than Titan Pharmaceuticals, Inc. (1.94%), greater than Oragenics, Inc. (-177.32%), greater than KALA BIO, Inc. (-1335.64%), greater than Xenetic Biosciences, Inc. (-39.28%), less than AIM ImmunoTech Inc. (261.84%), greater than VYNE Therapeutics Inc. (-69.57%), greater than Qualigen Therapeutics, Inc. (-94.09%), greater than Kazia Therapeutics Limited (-116.86%), greater than Can-Fite BioPharma Ltd. (-141.01%),
| Company | ROE | Market cap |
|---|---|---|
| -246.04% | $4.12M | |
| 1.94% | $3.11M | |
| -177.32% | $2.48M | |
| -1335.64% | $79.17M | |
| -39.28% | $5.29M | |
| 261.84% | $1.29M | |
| -69.57% | $10.59M | |
| -94.09% | $5.43M | |
| -116.86% | $22.45M | |
| -141.01% | $1.60M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ensysce Biosciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Ensysce Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Ensysce Biosciences, Inc.'s ROE?
How is the ROE calculated for Ensysce Biosciences, Inc. (ENSC)?
What is the highest ROE for Ensysce Biosciences, Inc. (ENSC)?
What is the 3-year average ROE for Ensysce Biosciences, Inc. (ENSC)?
What is the 5-year average ROE for Ensysce Biosciences, Inc. (ENSC)?
How does the current ROE for Ensysce Biosciences, Inc. (ENSC) compare to its historical average?